Noninvasive prenatal testing: the importance of pretest trisomy risk and posttest predictive values. - Suppr | 超能文献

Noninvasive prenatal testing: the importance of pretest trisomy risk and posttest predictive values.

作者信息

Wax Joseph R, Chard Renee, Cartin Angelina, Litton Christian, Pinette Michael G, Lucas F Lee

机构信息

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Maine Medical Center, Portland, ME.

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Maine Medical Center, Portland, ME.

出版信息

Am J Obstet Gynecol. 2015 Apr;212(4):548-9. doi: 10.1016/j.ajog.2014.12.033. Epub 2014 Dec 30.

DOI:10.1016/j.ajog.2014.12.033

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Noninvasive prenatal testing: the importance of pretest trisomy risk and posttest predictive values.

Am J Obstet Gynecol. 2015 Apr;212(4):548-9. doi: 10.1016/j.ajog.2014.12.033. Epub 2014 Dec 30.

2

DNA sequencing versus standard prenatal aneuploidy screening.DNA 测序与标准产前非整倍体筛查。

N Engl J Med. 2014 Feb 27;370(9):799-808. doi: 10.1056/NEJMoa1311037.

3

Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.常规临床实践中的无创产前检测——对澳大利亚未选择人群中无创产前检测和孕早期联合筛查的一项审计

Aust N Z J Obstet Gynaecol. 2016 Feb;56(1):22-8. doi: 10.1111/ajo.12432.

4

Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA.利用DNA大规模平行基因组测序技术对孕妇血液进行无创产前筛查，以检测胎儿21三体、18三体、13三体及常见性染色体非整倍体。

Am J Obstet Gynecol. 2014 Oct;211(4):365.e1-12. doi: 10.1016/j.ajog.2014.03.042. Epub 2014 Mar 19.

5

Clinical evaluation of the IONA test: a non-invasive prenatal screening test for trisomies 21, 18 and 13.IONA检测的临床评估：一种用于21、18和13三体综合征的非侵入性产前筛查检测

Ultrasound Obstet Gynecol. 2016 Feb;47(2):188-93. doi: 10.1002/uog.15791. Epub 2015 Dec 28.

6

Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.母血中游离DNA分析用于胎儿非整倍体筛查：更新的荟萃分析

Ultrasound Obstet Gynecol. 2015 Mar;45(3):249-66. doi: 10.1002/uog.14791. Epub 2015 Feb 1.

7

Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.游离胎儿DNA在母血中用于无创产前筛查

Clin Perinatol. 2014 Dec;41(4):957-66. doi: 10.1016/j.clp.2014.08.013. Epub 2014 Oct 1.

8

Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.母体外周血游离 DNA 检测筛查三体的结果失败：后果分析。

Ultrasound Obstet Gynecol. 2016 Jun;47(6):698-704. doi: 10.1002/uog.15851. Epub 2016 Apr 25.

9

IONA test for first-trimester detection of trisomies 21, 18 and 13.用于孕早期检测21、18和13三体的IONA检测

Ultrasound Obstet Gynecol. 2016 Feb;47(2):184-7. doi: 10.1002/uog.15749. Epub 2015 Dec 28.

10

Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.21、18和13三体综合征的无创产前检测：146958例妊娠的临床经验

Ultrasound Obstet Gynecol. 2015 May;45(5):530-8. doi: 10.1002/uog.14792. Epub 2015 Apr 8.

引用本文的文献

1

A Cost-Effectiveness Analysis of Screening Strategies Involving Non-Invasive Prenatal Testing for Trisomy 21.非侵入性产前检测用于 21 三体综合征筛查策略的成本效果分析。

Front Public Health. 2022 May 31;10:870543. doi: 10.3389/fpubh.2022.870543. eCollection 2022.

2

Screening for fetal chromosomal and subchromosomal disorders.胎儿染色体和亚染色体疾病筛查。

Semin Fetal Neonatal Med. 2018 Apr;23(2):85-93. doi: 10.1016/j.siny.2017.10.006. Epub 2017 Nov 8.